Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
Published on: August 30, 2024
Transcutaneous Temperature-controlled Radiofrequency for Vaginal Rejuvenation
Smit Bharat Solanki1, Vineet Mishra1, Nita Mishra2
1Department of Obstetrics and Gynecology, Institute of Kidney Diseases and Research Center, Dr. Hl Trivedi Institute of Transplantation Sciences, Ahmedabad, Gujarat, India.
Background:
Vaginal laxity and sexual dysfunction are commonly experienced by women, but are typically stigmatized and considered inappropriate to discuss openly. This study was designed to assess the effectiveness and safety of transcutaneous temperature-controlled radiofrequency (TTCRF), in addressing these concerns. The study used a single-blinded randomized sham-control design.
Aims And Objectives:
The aim was to study the role of TTCRF for vaginal rejuvenation using subjective and objective measurements.
Materials And Methods:
Two hundred parous women were randomly assigned to either a treatment group (n = 110) or a sham group (n = 90). Participants who were between 35 and 55 years of age and reported complaints of vaginal laxity, as well as those who presented symptoms such as vaginal flatus or sexual issues, were included. The treatment group was administered TTCRF therapy, whereas the sham group had a placebo procedure to ensure blinding was maintained. The outcome measures included subjective assessments, such as the Female Sexual Function Index (FSFI), the Vaginal Laxity Questionnaire (VLQ), the Vaginal Flatus Score (VFS), and the Vaginal Laxity and Bother Score (VLBS), as well as objective measurements, such as the Modified Oxford Score (MOS) and the Genital Hiatus (GH) questionnaire.
Results:
Baseline characteristics were comparable between the groups. Significant improvements in FSFI, VLQ, and VLBS were noted in the treatment group compared to sham at 1 month, 3 months, and 6 months. The MOS improvements did not reach statistical significance, suggesting potential limitations in its use as an objective measure. VFS showed improvement in both the groups, indicating a potential placebo effect. No significant changes were observed in GH. Adverse events were mild and transient, with no serious incidents reported.
Conclusion:
Despite societal taboos, TTCRF demonstrated notable improvements in subjective measures of vaginal laxity and sexual dysfunction over a 6-month period. The safety and outpatient feasibility of TTCRF were established. The findings contribute to understanding the role of TTCRF in managing these sensitive concerns among women.
Related Concept Videos
Assessing Body Temperature - Rectal
Follow these steps for rectal temperature assessment:
Step 1: Perform hand hygiene and don clean gloves to prevent cross-infection.
Step 2: Position the patient in a side-lying position to better visualize the rectal...
Decreased Body Temperature

